NEW

Health Care Leaders Form Trustworthy & Responsible AI Network (TRAIN)

Monday, at the HIMSS 2024 Global Health Conference, a new consortium of healthcare leaders announced the creation of the Trustworthy & Responsible AI Network (TRAIN), which aims to operationalize responsible AI principles to improve the quality, safety and...

EPA Rule to Slash EtO Emissions, Reduce Cancer Risk

The U.S. Environmental Protection Agency has announced a rule that will reduce lifetime cancer risks for people living near commercial sterilization facilities across the country. The final amendments to the air toxics standards for ethylene oxide commercial...

AI Revolutionizes General Surgery, says GlobalData

Artificial intelligence (AI) integration in general surgery has surged, promising revolutionary advancements in precision and patient outcomes. AI tools have transformed preoperative planning, intraoperative assistance, and postoperative care, enhancing diagnostic...

Study Shows Potential for Using AI Tools to Detect Healthcare-Associated Infections

A new proof-of-concept study published today in the American Journal of Infection Control (AJIC) reports that artificial intelligence (AI) technologies can accurately identify cases of healthcare-associated infections (HAI) even in complex clinical scenarios. The...

Metrex Surface Disinfectant Portfolio Secures EPA Approval

Metrex Surface Disinfectant Portfolio Secures EPA Approval

The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.

The new claim was approved based on third-party laboratory testing results that support Metrex’s portfolio of broad-spectrum surface disinfectants to be effective against SARS-CoV-2 according to EPA Product Performance Test Guidelines Disinfectants for Use on Environmental Surfaces, Guidance for Efficacy Testing (OCSPP 810.2200).

“Healthcare professionals find themselves working in rapidly-evolving and complex conditions that have increased the demands of infection control,” said James Chia, Director of Research and Development at Metrex. “The below Metrex’s surface disinfection products are effective against SARS-CoV-2, helping to give front-line workers peace of mind that our products are protecting their patients and themselves.”

The following Metrex products have been approved by the EPA for efficacy against

SARS-CoV-2 and are on the EPA list N for use against SARS-CoV-2:

  • CaviWipes 2.0
  • CaviWipes
  • CaviWipes1
  • CaviWipes Bleach
  • CaviCide
  • CaviCide1
  • MetriGuard
  • EnviroCide

CaviWipes and CaviCide surface disinfectant products clean and disinfect hard, non-porous, inanimate surfaces and non-critical medical device surfaces in hospitals, laboratories and other clinical care environments. Formulated to kill a broad spectrum of bacteria, viruses and pathogenic fungi quickly and efficiently, CaviWipes and CaviCide branded products support kill times from one to three minutes.

For more information, visit www.metrex.com.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X